基于RNA的抗瘤疗法的新兴进展
Jiayan Fu1,2,3, Haiyang Dong1,2,3, Jian Wu4
1National Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University, 310058, Hangzhou, China.
International journal of biological sciences
|July 7, 2023
概括
基于RNA的疗法在癌症治疗方面表现有前途. RNA修饰和传递系统的进步提高了它们的稳定性,效率和针对性,以获得有效的抗瘤反应.
科学领域:
- 生物技术是生物技术.
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 基于RNA的疗法,包括mRNA,siRNA,miRNA,ASO和saRNA,为癌症治疗提供了显著的潜力.
- 最近RNA修饰和传递系统的进步对于稳定和高效的*in vivo*RNA传递至关重要.
研究的目的:
- 审查基于RNA的抗瘤疗法的进展情况.
- 讨论RNA修改,传递系统和作用机制的优化.
- 评估各种RNA载荷用于癌症治疗的潜力和局限性.
主要方法:
- 对基于RNA的抗瘤疗法的当前文献进行了全面的审查.
- 分析关键方面,包括免疫性,稳定性,翻译效率和传递方法.
- 在癌症治疗中讨论RNA吸收体和基于CRISPR的基因编辑.
主要成果:
- 开发具有增强特异性和疗效的向RNA疗法.
- 对RNA修饰和传递系统的优化策略改善了*in vivo*的性能.
- 了解基于RNA的药物引起抗瘤反应的机制.
结论:
- 基于RNA的疗法,包括mRNA,siRNA,miRNA,ASO和saRNA,正在迅速发展为癌症治疗.
- 对RNA修饰,传递和机制的持续研究将进一步释放它们对各种癌症的治疗潜力.
相关概念视频
Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
siRNA - Small Interfering RNAs
16.9K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.9K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Types of RNA
64.0K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
64.0K


